Polaris Partners Leads USD43m Series A for Singaporean Drug Discovery Platform Engine Biosciences
Source(s): Tech in Asia
Polaris Partners led a USD43m Series A for Singapore-based drug discovery platform Engine Biosciences, with follow-on from 6 Dimensions Capital, WuXi AppTec, DHVC, EDBI, Baidu Ventures, Vectr Ventures, Goodman Capital, WI Harper and Nest Bio Labs. Read more